The Center
Multiple Sclerosis Center Dresden
Patient Information
Contact MSC
Physicians & Nurses
Study Team
Neuropsychology
Mobility Center
The Mobility Center
Walking Assessment
Jump Assessment
DIERS
EMIQ
Projects
Neuroimmunological Laboratory
The NIL
Neurofilament light chain
Autonomic & Neuroendocrinological Functional Laboratory
The ANF
ANF Assessment
MS Living Lab
Management & Science
Team Management & Science
Projects
eHealth & Analytics
MSDS 3D
MSDS Clinic & Practice
MS-HRS
MTRS
Multiple Sclerosis Management
Aktuelles
Neuigkeiten
Publikationen
Veranstaltungen
Adventssymposium
Multiple Sklerose 360°
Welt-MS-Tag 2021
Doktorarbeiten
Jobs
Kontakt
Podcasts & Newsletter
Newsletter
Patienten-Podcast
Ärzte-Podcast
Neurovision
Studien
Interventionelle Studien
B-SHUTTLE
Nicht-interventionelle Studien
MS PATHS
Konectom
Sprachanalyse
English (UK)
Deutsch
English (UK)
Chances and Challenges of Registry-Based Pharmacovigilance in Multiple Sclerosis: Lessons Learnt from the Implementation of the Multicenter REGIMS Registry
MASC
Jahr
Publikationsjahr
2021
Autoren
Autorenliste der Publikation
Simbrich A, Thibaut J, Khil L, Maximov S, Wiendl H, Berger K; REGIMS Investigators.
Verlag
Publisher-Information
Drug Saf. 2021 Jan;44(1):7-15.
Link
Zur Publikation (externer Server)
https://doi.org/10.1007/s40264-020-01007-1
Tags
Forschungsthemen
Multiple Sklerose
MS Behandlung
Management & Science
MASC
2021
Higher effect sizes for the detection of accelerated brain volume loss and disability progression in multiple sclerosis using deep-learning
MASC
Jahr
2024
Integrating large language models in care, research, and education in multiple sclerosis management
MASC
Jahr
2024
A 2-stage model of heterogenous treatment effects for brain atrophy in multiple sclerosis utilizing the MS PATHS research network
Multiple Sclerosis
Jahr
2024
A future of AI-driven personalized care for people with multiple sclerosis
MASC
Jahr
2024
Rule-Based DSL for Continuous Features and ML Models Selection in Multiple Sclerosis Research
MASC
Jahr
2024
